Why I Sold Crescita Therapeutics

This past week I sold my entire position in Crescita Therapeutics. In Q3 Crescita collected a $5 million royalty payment that was owed to them by Taro Pharmaceuticals. The collection…

Comments Off on Why I Sold Crescita Therapeutics

NamSys Q2 2020 Results

On June 24th, 2020, NamSys Q2 2020 results were released. The company continues to show growth in a challenging COVID-19 environment. Revenue was up 14.5% for Q2 and up 19.2%…

Comments Off on NamSys Q2 2020 Results

Crescita Q1 2020 Results

On May 26th Crescita Q1 2020 results were released. Crescita was cash-flow positive without any milestone or upfront payments from Pliagis agreements. This quarter gives us a good look at…

Comments Off on Crescita Q1 2020 Results

Keystone Financial Podcast Review

The Keystone Financial Stock Talk podcast is a weekly podcast hosted by Ryan Irvine and Aaron Dunn. They take a look at various companies using different segments like their "Star"…

Comments Off on Keystone Financial Podcast Review